These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17352682)

  • 41. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
    Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
    ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure based lead optimization approach in discovery of selective DPP4 inhibitors.
    Ghate M; Jain SV
    Mini Rev Med Chem; 2013 May; 13(6):888-914. PubMed ID: 23170960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues.
    Dubois V; Van Ginneken C; De Cock H; Lambeir AM; Van der Veken P; Augustyns K; Chen X; Scharpé S; De Meester I
    J Histochem Cytochem; 2009 Jun; 57(6):531-41. PubMed ID: 19188489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
    Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
    Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
    J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer.
    Busek P; Malík R; Sedo A
    Int J Biochem Cell Biol; 2004 Mar; 36(3):408-21. PubMed ID: 14687920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
    Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
    Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
    Huan Y; Jiang Q; Liu JL; Shen ZF
    J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
    Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
    Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.
    Stöckel-Maschek A; Stiebitz B; Born I; Faust J; Mögelin W; Neubert K
    Adv Exp Med Biol; 2000; 477():117-23. PubMed ID: 10849737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors.
    Jiang T; Zhou Y; Zhu J; Chen Z; Sun P; Zhang Q; Wang Z; Shao Q; Jiang X; Li B; Wang H; Zhu W; Shen J
    Arch Pharm (Weinheim); 2015 Jun; 348(6):399-407. PubMed ID: 25871012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis.
    Nongonierma AB; FitzGerald RJ
    Food Chem; 2014 Feb; 145():845-52. PubMed ID: 24128555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of potent dipeptidyl peptidase IV (DPP-4) inhibitors by employing a strategy to form a salt bridge with Lys554.
    Maezaki H; Tawada M; Yamashita T; Banno Y; Miyamoto Y; Yamamoto Y; Ikedo K; Kosaka T; Tsubotani S; Tani A; Asakawa T; Suzuki N; Oi S
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3565-3571. PubMed ID: 28579121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the susceptibility of porcine and human dipeptidyl-peptidase IV to inhibition by protein-derived peptides.
    Lacroix IM; Li-Chan EC
    Peptides; 2015 Jul; 69():19-25. PubMed ID: 25828735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptide VPYPQ and Its Controlled Release from Casein by Enzymatic Hydrolysis.
    Zheng L; Xu Q; Lin L; Zeng XA; Sun B; Zhao M
    J Agric Food Chem; 2019 Sep; 67(38):10604-10613. PubMed ID: 31466448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel DPP-4 inhibitors against diabetes.
    Liu Y; Hu Y
    Future Med Chem; 2014 May; 6(7):793-808. PubMed ID: 24941873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of dipeptidyl peptidase II, dipeptidyl peptidase IV, and prolyl endopeptidase in effusion from patients with serous otitis media.
    Rao AJ; Hagihara M; Nagatsu T; Yanagita N
    Biochem Med Metab Biol; 1990 Jun; 43(3):276-82. PubMed ID: 1974452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
    Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.